Psychemedics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Psychemedics generated cash of -$1,480,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,147,000 last year. Net change in cash is therefore -$2,786,000.
Cash Flow
| 2014 | 4.45M | -7.80M | 2.99M |
|---|---|---|---|
| 2015 | 4.57M | -1.79M | -3.70M |
| 2016 | 9.26M | -2.09M | -5.92M |
| 2017 | 9.14M | -1.24M | -3.45M |
| 2018 | 7.92M | -5.35M | -5.63M |
| 2019 | 4.30M | 2.07M | -3.00M |
| 2020 | -4.08M | -858K | 501K |
| 2021 | 414K | -220K | -1.03M |
| 2022 | 4.89M | -208K | -1.92M |
| 2023 | -1.48M | -159K | -1.14M |
PMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.75M | 1.99M | 2.83M | 7.28M | 4.06M | 8.16M | 3.93M | 2.68M | 3.61M | 3.97M |
Operating activities | ||||||||||
Net income | -4.15M | -1.08M | -665K | -3.85M | 1.54M | 4.58M | 6.12M | 6.67M | 1.51M | 3.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.67M | 3.31M | 3.69M | 3.62M | 2.91M | 3.06M | 2.80M | 2.29M | 1.73M | 1.05M |
Stock-based compensation expense | 908K | 872K | 743K | 563K | 759K | 594K | 582K | 671K | 673.85K | 608.64K |
| Deferred income tax benefit | 908K | 872K | 743K | 563K | 759K | 594K | 582K | 671K | 673.85K | 608.64K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 373K | 377K | -760K | 424K | 1.04M | -355K | 1.31M | -2.29M | 539.36K | 290.73K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 304K | -546K | 417K | -281K | -494K | 77K | -990K | 144K | -97.78K | 334.52K |
Cash generated by operating activities | -1.48M | 4.89M | 414K | -4.08M | 4.30M | 7.92M | 9.14M | 9.26M | 4.57M | 4.45M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -4.03M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -157K | -187K | -182K | -991K | -1.73M | -1.32M | -1.24M | -2.09M | -1.79M | -7.80M |
Acquisitions Net | 0 | 0 | 0 | 140K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -159K | -208K | -220K | -858K | 2.07M | -5.35M | -1.24M | -2.09M | -1.79M | -7.80M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 72K | -9K | 0 | 0 | 0 | 0 | 199K | 260K |
Payments for dividends | -799K | -1.18M | -279K | -993K | -3.97M | -3.79M | -3.28M | -3.26M | -3.24M | -3.21M |
Repurchases of common stock | -54K | -78K | -72K | -9K | -33K | -93K | -163K | -149K | -199K | -260K |
Repayments of term debt | -294K | -664K | -688K | -678K | 1.00M | -1.74M | -4K | -2.51M | -358K | -751.54K |
Cash used in financing activities | -1.14M | -1.92M | -1.03M | 501K | -3.00M | -5.63M | -3.45M | -5.92M | -3.70M | 2.99M |
Net Change In Cash | -2.78M | 2.75M | -841K | -4.45M | 3.21M | -4.09M | 4.22M | 1.24M | -922.68K | -358.35K |
Cash at end of period | 1.96M | 4.75M | 1.99M | 2.83M | 7.28M | 4.06M | 8.16M | 3.93M | 2.68M | 3.61M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |